« Zurück
Home /
PI3KCG Antibody (Center) Blocking Peptide

PI3KCG Antibody (Center) Blocking Peptide

ArtNr	ABC-BP8180c
Hersteller	Abcepta
Menge	500 ug
Kategorie	Peptides & Proteins Peptides
Typ	Peptides
Format	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Similar products	PIK3CG, Phosphatidylinositol 4, 5-bisphosphate 3-kinase catalytic subunit gamma isoform, 5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma, Phosphoinositide-3-kinase catalytic gamma polypeptide, PI3Kgamma, PI3-kinase subunit gamma, PI3K-gamma, PtdIns-3-kinase subunit gamma, PtdIns-3-kinase subunit p110-gamma, p110gamma, Serine/threonine protein kinase PIK3CG, p120-PI3K
Lieferbar
Primary Accession	P48736
Bio Background	PI3KCG belongs to the pi3/pi4-kinase family of proteins. It is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. It is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In addition to its role in promoting assembly of adherens junctions, the protein is thought to play a pivotal role in the regulation of cytotoxicity in NK cells. The gene for this protein is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias.
Bio References	Andreozzi, F., et al., Endocrinology 145(6):2845-2857 (2004).Reddy, S.A., et al., Biochem. Biophys. Res. Commun. 316(4):1022-1028 (2004).Osaki, M., et al., J. Cancer Res. Clin. Oncol. 130(1):8-14 (2004).Khan, N.A., et al., J. Neurovirol. 9(6):584-593 (2003).Theberge, J.F., et al., Arch. Biochem. Biophys. 420(1):9-17 (2003).
Gene ID	5294
Gene Name	PIK3CG
Subtitle	Synthetic peptide
Target/Specificity	The synthetic peptide sequence used to generate the antibody AP8180c was selected from the Center region of human PI3KCG. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

ABC-BP8180c-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 500 ug

lieferbar

Lieferung vsl. bis 08.11.2024

Express-Lieferung: 32 Tage sparen

Vergleichen

Auf den Wunschzettel

Weiterempfehlen per Mail